<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1463">
  <stage>Registered</stage>
  <submitdate>2/02/2007</submitdate>
  <approvaldate>2/02/2007</approvaldate>
  <nctid>NCT00431418</nctid>
  <trial_identification>
    <studytitle>The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease</studytitle>
    <scientifictitle>The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease (SPICE Trial): a Pilot Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>R 06/34</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lung Diseases</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Sildenafil
Treatment: drugs - Placebo

Active Comparator: 1 - Sildenafil oral solution.

Placebo Comparator: 2 - Placebo oral solution.


Treatment: drugs: Sildenafil
Sildenafil oral solution

Treatment: drugs: Placebo
Placebo solution

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Length of ventilation</outcome>
      <timepoint>12 months after completion of study</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Bronchopulmonary Dysplasia (BPD)</outcome>
      <timepoint>12 months after completion of study</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Newborn babies born &lt;28 weeks of gestation who still need ventilatory support via
             endotracheal tube or have been re-ventilated at day 7 of life.</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>7</inclusivemaxage>
    <inclusivemaxagetype>Days</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Congenital heart defects

          -  Suspected inborn error of metabolism

          -  Inhaled Nitric Oxide treatment during assessment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3 />
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>20</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/06/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Mercy Hospital for Women - Heidelburg</hospital>
    <postcode>3084 - Heidelburg</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Mercy Hospital for Women, Australia</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this pilot study is to investigate in a randomised double-blind trial whether
      treatment with Sildenafil reduces duration of ventilatory support in preterm infants born at
      28 weeks of gestation or less.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00431418</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kai KÃ¶nig, MD</name>
      <address>Mercy Hospital for Women</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>